Stories

For the last year, Emily Fernholz’s time has been consumed by COVID-19. But as the pandemic has eased, she’s turned her attention back to the usual business of Mayo’s Clinical Virology/Parasitology Laboratory: testing for virus-, parasite-, and vector-borne diseases.

This week's research roundup features a study on the prognostic role of MYC structural variants identified by NGS and FISH in multiple myeloma.

Top highlights include: Changes to outpatient visitor restrictions in Rochester, MN, Mayo Clinic Q&A podcast on the COVID-19 delta variant, and respiratory illnesses on the rise with symptoms similar to COVID-19.

Mayo Clinic renal pathologist Dr. Sanjeev Sethi identified NELL-1 as a biomarker for membranous nephropathy (MN) in 2019. Two years later, Dr. Sethi helped implement the first ever IHC test to detect NELL-1 antigen, which appears in about 10% of MN patients and is linked to underlying malignancy.

This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.

Topic includes: new vaccine platform invented by Mayo enters COVID-19 clinical trial, Q&A on vaccination and precautions and the new work-life balancing act.

Mayo Clinic’s Advanced Diagnostics Laboratory (ADL) is a visionary space designed to foster innovation. The ADL has a direct impact on patient lives, bringing promising tests and services to patients at Mayo and around the world.

Shawn Mitchell brings a wealth of laboratory expertise to his role as a senior product manager at Mayo Clinic Laboratories, where he puts his knowledge to work promoting Mayo’s innovative infectious disease testing.

This week’s research roundup features a study on how ciliopathy protein HYLS1 coordinates the biogenesis and signaling of primary cilia by activating the ciliary lipid kinase PIPKIγ.

This week’s research roundup features a study on MAP3K7-IKK inflammatory signaling modulates AR protein degradation and prostate cancer progression.

This week’s research roundup features a study on acute treatments for episodic migraine in adults: A systematic review and meta-analysis.

Top stories include: COVID-19 travel tips for people with weakened immune systems, Mayo clinic Q&A on examining reports of heart inflammation in young people after second COVID-19 vaccine, and what Mayo Clinic has to offer with COVID-19 walk in vaccine clinics in Minnesota.

Delta Health leveraged their relationship with Mayo Clinic Laboratories to support patient in rural Colorado during the COVID-19 pandemic. Delta Health and Mayo Clinic Laboratories have collaborated for over 17 years to perform complex and esoteric testing.